iBio, Inc. (IBIO) – Hot FDA News
-
iBio, Inc. (IBIO) Successful Preclinical Immunization Studies with Next-Gen Nucleocapsid COVID-19 Vaccine Candidate
-
iBio, Inc. (IBIO) Reports Successful COVID-19 Vaccine Toxicology Study Results and Announces Next-Gen COVID-19 Vaccine Program
-
-
-
-
-
-
Back to IBIO Stock Lookup